Torrey Pines Institute

Torrey Pines Institute for Molecular Studies is internationally recognized for its new methods of drug discovery and its basic research into multiple sclerosis, diabetes, immunology, infectious disease, regenerative medicine, obesity, heart disease, cancer vaccines and pain management.

The Institute was formed by Richard A. Houghten, Ph.D. in 1988 to develop breakthroughs that he made as a researcher with the Scripps Research Institute. Of principal interest were his discoveries in peptide synthesis along with technologies for using those peptides, and other compounds, as an alternative means of drug discovery.

Now employing a multidisciplinary staff of close to 200 people, Torrey Pines Institute has moved its headquarters and the bulk of its operation to TCI.